Expression of VCAN and its receptors in canine mammary carcinomas with or without myoepithelial proliferation. (November 2021)
- Record Type:
- Journal Article
- Title:
- Expression of VCAN and its receptors in canine mammary carcinomas with or without myoepithelial proliferation. (November 2021)
- Main Title:
- Expression of VCAN and its receptors in canine mammary carcinomas with or without myoepithelial proliferation
- Authors:
- Figuerêdo, S.H.
Neto, R.S. Carmo
Ferreira, E.
Cassali, G.D.
Estrela-Lima, A.
Damasceno, K.A. - Abstract:
- Abstract: The proteoglycan versican (VCAN) plays a complex role in cancer. The expression of this molecule has been related to invasion and progression in malignant mixed tumors, such as carcinoma in mixed tumors (CMT) of the canine mammary gland. In addition, its interaction with surface cell receptors EGFR, HER-2 and CD44 in malignant epithelial cells may be responsible for proliferation and cellular motility in early stages of cancer. We comparatively evaluated the expression of this proteoglycan and its receptors in in situ and invasive areas of simple carcinomas (SC) and CMT to investigate similarities and differences between these histological types. Immunohistochemistry was performed with anti-VCAN, anti-CD44, anti-EGFR and anti-HER-2 antibodies in 32 cases of SC or CMT. VCAN was highly expressed in stroma adjacent to invasive areas in SC and CMT. CMTs presented comparatively higher expression of VCAN in stroma adjacent to in situ and in invasive areas than in corresponding areas in SCs. In CMT, EGFR and HER-2 expressions were higher in situ compared to invasive areas. In contrast, increased CD44 and EGFR expression was found in invasive areas in SC compared to CMT. These results indicate that versican expression is similarly associated with invasiveness in SC and CMT, however higher levels were seen in CMT suggesting that the presence of myoepithelial proliferation in this tumor type participates in stromal composition and promoting an increase in the expression ofAbstract: The proteoglycan versican (VCAN) plays a complex role in cancer. The expression of this molecule has been related to invasion and progression in malignant mixed tumors, such as carcinoma in mixed tumors (CMT) of the canine mammary gland. In addition, its interaction with surface cell receptors EGFR, HER-2 and CD44 in malignant epithelial cells may be responsible for proliferation and cellular motility in early stages of cancer. We comparatively evaluated the expression of this proteoglycan and its receptors in in situ and invasive areas of simple carcinomas (SC) and CMT to investigate similarities and differences between these histological types. Immunohistochemistry was performed with anti-VCAN, anti-CD44, anti-EGFR and anti-HER-2 antibodies in 32 cases of SC or CMT. VCAN was highly expressed in stroma adjacent to invasive areas in SC and CMT. CMTs presented comparatively higher expression of VCAN in stroma adjacent to in situ and in invasive areas than in corresponding areas in SCs. In CMT, EGFR and HER-2 expressions were higher in situ compared to invasive areas. In contrast, increased CD44 and EGFR expression was found in invasive areas in SC compared to CMT. These results indicate that versican expression is similarly associated with invasiveness in SC and CMT, however higher levels were seen in CMT suggesting that the presence of myoepithelial proliferation in this tumor type participates in stromal composition and promoting an increase in the expression of versican. Highlights: The expression of intratumoral versican is related to the invasiveness of carcinomas of the canine mammary gland. Myoepithelial cells are important to versican expression. Carcinomas in mixed tumors express more versican than simple carcinomas possibly due to the presence of myoepithelial cells … (more)
- Is Part Of:
- Research in veterinary science. Volume 140(2021)
- Journal:
- Research in veterinary science
- Issue:
- Volume 140(2021)
- Issue Display:
- Volume 140, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 140
- Issue:
- 2021
- Issue Sort Value:
- 2021-0140-2021-0000
- Page Start:
- 56
- Page End:
- 63
- Publication Date:
- 2021-11
- Subjects:
- Canine -- Cancer progression -- Extracellular matrix -- Versican
Veterinary medicine -- Periodicals
Veterinary Medicine -- Periodicals
Médecine vétérinaire -- Périodiques
Médecine vétérinaire -- Recherche -- Périodiques
Diergeneeskunde
636.089 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00345288 ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/research-in-veterinary-science/ ↗
http://www.harcourt-international.com/journals ↗ - DOI:
- 10.1016/j.rvsc.2021.08.010 ↗
- Languages:
- English
- ISSNs:
- 0034-5288
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7774.100000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 19489.xml